Skip to main content

Progesterone-mediated effects on gene expression and oocyte-cumulus complex transport in the mouse fallopian tube



The fallopian tube transports the gametes to the fertilization site and delivers the embryo to the uterus at the optimal time for implantation. Progesterone and the classical progesterone receptor are involved in regulating both tubal ciliary beating and muscular contractions, likely via both genomic and non-genomic actions.


To provide more details of the underlying mechanisms, we investigated the effect of progesterone on gene expression in mice fallopian tubes in vitro at 20 min, 2 h and 8 h post progesterone treatment using microarray and/or quantitative PCR. In parallel, oocyte cumulus complex transport was investigated in ovulating mice that were injected with one of the progesterone receptor antagonists, Org 31710 or CDB2194.


Microarray analyses did not reveal any apparently regulated genes 20 min after progesterone treatment, consistent with the proposed non-genomic action of progesterone controlling ciliary beating. After 2 h, 11 genes were identified as up-regulated. Analyses using quantitative PCR at 2 h and 8 h showed a consistent up-regulation of endothelin1 and a down-regulation of its receptor Endothelin receptor A by progesterone. We also confirmed that treatment with progesterone receptor antagonists before ovulation accelerates the transport of the oocyte cumulus complex.


This is the first study showing that progesterone regulates the expression of endothelin1 and endothelin receptor A in the fallopian tube. Together with previous studies of the effects of endothelin on muscular contractions in the fallopian tube, the results from this study suggest that endothelin is a mediator of the progesterone-controlled effects on muscular contraction and eventually gamete transport in the fallopian tube.


The fundamental steps in female reproduction include the transport of the oocyte cumulus complex (OCC) from the site of ovulation to the site of fertilization and further transport of the fertilized embryo to the site of implantation. The fallopian tube provides the ways and means of this process by muscular contraction, ciliary movement and flow of secretions [1], which are influenced and affected by progesterone and the classical progesterone receptor (PGR) [24]. The roles of progesterone in the ovary, uterus and mammary gland have been well described, but its role and detailed mode of action in the fallopian tube are not as well defined. Overall, progesterone affects processes that influence and optimize the transport of the OCC to the site of fertilization as well as nourish and transport the embryo to the uterus. Because progesterone acts to increase the chance of a successful implantation, it is important to also reveal the mechanisms behind its actions in the fallopian tube [58].

Progesterone is involved in the regulation of the frequency of muscle contractions in human fallopian tubes in vitro in a dose-dependent manner [9]. The regulation of muscle contractions is complex and influenced by several factors, such as sex steroids, prostaglandins and endothelins [915]. Estrogen promotes muscular contraction, and progesterone promotes relaxation [10, 15]. Prostaglandins seem to have a dual effect on contractility where the E-series (PGE) relaxes muscle activity and the F-series (PGF) induces muscle activity. This response appears to be influenced by ovarian steroids, as progesterone increases the response to PGE1 and decreases the response to PGF2alpha [16]. Research have shown that the expression of PGE and PGF2alpha receptors are affected by mifepristone (RU486), an antagonist to both corticoid and progesterone receptors, suggesting that prostaglandin receptors in the fallopian tube are directly or indirectly regulated by progesterone [17]. The role of endothelins in the fallopian tube is relatively well established. Both endothelin 1 (EDN1) and endothelin 2 (EDN2) have been shown to increase muscular contractility in the fallopian tube [1113]. One in vitro study by Wanggren et al. demonstrated the effects of 100 nM progesterone on muscle contractions in the fallopian tube within 20 min [9]. Such a rapid time course supports the hypothesis that progesterone regulates muscular activity through both transcriptional and non-transcriptional pathways. In the study by Wanggren, the effect of progesterone was not blocked by the antagonist mifepristone (RU486), which could indicate the involvement of a receptor other than the PGR. However, progesterone and RU486 was administered at the same time and at equal concentrations, which may not be sufficient for efficient blockage [18, 19].

The exact location of the PGR in the fallopian tube is under debate. Immunohistochemistry data suggest a location in the lower half of the cilia in both mouse and human fallopian tubes [20]. Another study suggests a PGR location in the nuclear compartments of the luminal, epithelial and smooth muscle cells in the mouse fallopian tube [21]. In addition to the PGR, there are several candidate receptors that could potentially mediate the non-transcriptional effects of progesterone, including the membrane progesterone receptors (mPRs) [22]. Two isoforms of mPRs are present in the fallopian tube in both humans and mice, and both isoforms are regulated by progesterone [23, 24].

It is now well documented that progesterone decreases the ciliary beat frequency (CBF) of the fallopian tube. In humans, a high concentration of progesterone (10 μmol/L) reduced the CBF by 40–50 % 24 h after exposure [2]. In a similar study on ciliary cells from bovine oviduct, 20 μmol/L progesterone caused a reduction in the CBF within 30 min after exposure [19]. Studies in our laboratory on ciliary cells from mice have demonstrated an even faster (10–20 min) significant reduction of CBF by progesterone, using physiologically relevant concentrations of progesterone in the range of 10–100 nmol/L [4, 18]. We have previously established the involvement of the classical PGR in these rapid effects of progesterone on CBF. The reduction in CBF was induced when ciliary cells were exposed both to progesterone and promegestone, a specific agonist to PGR, and the reduction in CBF was blocked when ciliary cells were pre-treated with excess RU486 before exposure to progesterone. In mice lacking a functional Pgr, there was no reduction in CBF after progesterone administration [18]. Taken together, these findings indicate that PGR mediate the rapid CBF response to progesterone in the fallopian tube. The rapid effects suggest a non-genomic response may be involved, but data on the potential rapid changes in gene transcription in the fallopian tube following progesterone treatment are not known.

Studies have also suggested that PGR directly affects OCC and embryo transport of the fallopian tube in vivo. In one study, rats were treated with RU486 from the day of ovulation after which the fallopian tubes and uteri were flushed at different time points. In rats treated with RU486, the eggs arrived approximately 11 h earlier to the uterus than in the control rats. In another study, mice were administered a daily subcutaneous injection of two different progesterone receptor antagonists, RU486 and ZK98734, or vehicle during the 3 first days of pregnancy, and the uteri were flushed on the afternoon of day 3. Both antagonists significantly increased the number of embryos in the uterus compared to the control i.e., stimulated premature entry to the uterus [25, 26].

We hypothesize that PGR-mediated gene expression in the fallopian tube is part of the short and/or long-term regulation of OCC transport. We have started to address this by investigating global gene expression in the mouse fallopian tube after progesterone treatment in vitro to exclude indirect effects mediated by modulating the secretion of other hormones within the hypothalamus-pituitary-gonadal axis. The timing of regulation as well as the identity of these genes could provide insight into the mechanisms of progesterone-regulated OCC transport. Furthermore, the functional role of progesterone and PGR in the transport of the OCC in the fallopian tube was confirmed. The distribution of the PGR in the mouse fallopian tube was also investigated.



All animal experiments were approved by the local animal ethics committee in Gothenburg, Sweden, (50/2011) to DGJL and (58/2007) to RS. The mice used in this study were all immature female (3.5–5 weeks old) C57BL/6 N mice from Charles River, Kisslegg, Germany. The animals were housed under a 12:12 h light-dark schedule at 21 °C ± 2 °C with unlimited access to food and water. Before the start of experiment, the animals were allowed to acclimate to the animal facilities for ≥ 5 days.

In vivo treatment with progesterone antagonists and assessment of OCC transport

To investigate the role of PGR in OCC transport, ovulation was stimulated in 105 immature mice by intraperitoneal injection (i.p) of 5 IU Pregnant mare's serum gonadotropin (PMSG) (N .V. Organon, Oss, Holland) followed 48 h later by i.p injection of 5 IU of human chorionic gonadotropin (hCG) (N.V. Organon, Oss, Holland). In rodents, ovulation occurs 12–14 h after PMSG/hCG treatment. To determine whether a single dose of a PGR antagonist influences ovum transport, 40 of the PMSG/hCG-treated mice received an i.p. injection of Org31710 (8 μg/g) 6 h after the hCG injection, 25 were instead treated with another more specific PGR antagonist CDB2194 (8 μg/g) [2729], whereas 40 control mice were administered human chorionic gonadotropin vehicle only. The time point for the antagonist injection was chosen because we wanted to administer the antagonist before the OCCs were released into the fallopian tube but not too early to risk blocking the ovulation process. Both antagonists were dissolved in ethanol and suspended in sesame oil, whereas control mice were administered ethanol and sesame oil only (i.p. injection volume 100 μl). Both Org31710 and CDB2194 are more potent and show less anti glucocorticoid activity than other PGR antagonists such as RU486 and ZK 98299 [30]. We use two antagonists to show with higher certainty that the effect is indeed through the PGR. The doses of Org31710 and CDB2194 were chosen based on previous studies [28, 30]. All drug solutions were freshly prepared before each experiment. Mice from each treatment group were killed by cervical dislocation, and their fallopian tubes were removed, dissected and examined under a dissecting microscope at 24, 27, 30, 36, and 48 h after hCG injection. The presence of OCCs in the fallopian tubes were determined by flushing the fallopian tubes and observing if any OCCs were retrieved under the microscope. Please note that the females were kept in cages without males, and thus, there were no fertilized eggs present.

Tissue collection and progesterone exposure in vitro

Immature female mice (not treated with any hormones) were anesthetized by inhalation of isoflourane and then killed by inhalation of carbon dioxide followed by dissection. Both fallopian tubes were immediately removed and washed in pre-warmed (37 °C) G-MOPS™ (Vitrolife, Gothenburg, Sweden). G-MOPS is a medium specially developed for handling and manipulation of oocytes and embryos under normal air. After the removal of the broad ligaments, fat and blood vessels, the whole fallopian tubes, including all segments (total length approximately 18 mm) were longitudinally opened, cut into smaller pieces and then transferred to a new petri dish containing 2 ml pre-warmed G-MOPS™. In fallopian tubes from mice in this stage of development, ciliary cells and secretory cells are clearly visible [23]. Progesterone (>99 % purity, Sigma-Aldrich, St Louis, MO) was first dissolved in ethanol and then further dissolved in G-MOPS™. To add progesterone to the fallopian tubes, half of the medium in the petri dish was removed and replaced with an equal amount of medium containing progesterone and ethanol resulting in a final concentration of 100 nmol/L progesterone and 0.01 % (v/v) ethanol. The fallopian tubes in the control samples were exposed to ethanol (0.01 % (v/v)) only. The concentration of progesterone was based on results from our previous studies demonstrating clear effects on ciliary motility in this in vitro model [4, 18]. From each mouse, one fallopian tube was exposed to progesterone and one was used as the control. A total number of 48 mice and 96 fallopian tubes were used. The tissue samples were exposed for 20 min or 2 h, and immediately after exposure, they were snap-frozen in liquid nitrogen and stored at −80 °C until RNA extraction. To obtain sufficient quantities of RNA for the microarray analyses, six fallopian tubes (three animals) were pooled in one petri dish to form one sample. For each time point, we had four sample pairs resulting in a total of 16 samples. For additional gene expression analysis with quantitative PCR (qPCR), the fallopian tubes from an additional 36 mice were exposed to 100 nmol/L progesterone or control medium for 2 h or 8 h, resulting in four groups. For this analysis, less RNA was required, and the fallopian tube tissue from one mouse was sufficient to analyze as an independent sample. Thus, in total, nine samples from nine separate mice from each treatment group were analysed using qPCR. Immediately after exposure, the samples were snap−frozen in liquid nitrogen and stored at −80 °C.

RNA extraction and gene expression analysis

Fallopian tube samples were removed from liquid nitrogen storage and homogenized using a Tissue Lyser (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy Plus micro Kit (Qiagen) according to the manufacturer’s protocol. RNA quality and quantity were evaluated based on spectrophotometric measurements (Nanodrop 1000, NanoDrop Technologies, USA) and possible RNA degradation was measured with an RNA StdSens analysis kit and Experion (Experion™ Electrophoresis Station, Bio-Rad laboratories, Hercules, CA).

Microarray analyses

The gene expression in the fallopian tube after exposure to progesterone for 20 min or 2 h was analysed by microarray performed at the Swegene Centre for Integrative Biology (SCIBLU) at Lunds University, Lund, Sweden. In short, 500 ng total RNA was processed using the Illumina®Totalprep-96RNA Amplification kit 4397949 RevD, (Illumina) according to the manufacturer’s instructions to generate double stranded cDNA. The cDNA was used as a template to produce biotin-labeled cRNA according to the manufacturer’s specifications. The cRNA was then hybridized on to MouseRef-8 v2 Expression BeadChip using Whole-Genome Gene Expression Direct Hybridization Assay (Illumina) following the manufacturer’s instructions. The Beadchips were scanned in the iScan system using the Standard Illumina iScan N240 scanning protocol. Experimental quality analyses, probe summarization and quantile normalization [31] were performed using the GenomeStudio software V2011.1. Probe sets without signal intensity, i.e., intensity above the median of negative control intensity signals, in 80 % of the samples were excluded. Probe sets with no gene annotations or expired annotations were filtered. A paired (four sample pairs exposed for 20 min and four sample pairs exposed for 2 h) Significance Analysis of Microarrays (SAM) [32] was preformed to identify differently expressed genes between the groups using the TMEV v4.0 software [33]. For each gene, a q-value was reported. The q-value is similar to the more well-known p-value but adapted to multiple testing situations. Genes with a q-value ≤20 were considered differentially expressed. Data from the microarray experiment is available with accession number GSE61407 at the NCBI Gene Expression Omnibus public repository (GEO) according to MIAME guidelines. The time point of 20 min was chosen to be able to identify possible genes involved in regulating the rapid reduction in CBF observed in our previous papers within that time period. We choose two hours as our second time point because we had previously established that the ciliary activity remains stable for at least two h of incubation [4, 18].

Quantitative PCR

Four genes (Edn1, Amigo2, Arlf4 and Rasd1) that tended to be differentially expressed after 2 h of progesterone exposure, as measured by the microarray analysis, were further assessed with quantitative PCR analysis. The genes were selected based on their fold change and a connection to progesterone or PGR in the literature. However, no PCR products were obtained for Arlf4 (data not shown). The gene expression of five additional genes (Pgr, Edn2, Edn3, Ednra, Ednrb) was also assessed. These genes were not regulated according to the microarray but were selected based on a potential role in gamete transport. The analysis was performed on new samples from 36 mouse fallopian tubes exposed to progesterone (or control) for 2 h or 8 h in vitro. From each sample 1 μg of RNA was reverse-transcribed with a mixture of random hexamers and oligo (dt) primers, using the iScript cDNA Synthesis Kit (Bio-Rad). cDNA synthesis was performed according to the manufacturer’s protocol. The template cDNA, TaqMan Gene Expression master mix and pre-formulated primers and probes purchased as TaqMan Gene Expression assays (Life Technologies) were mixed and run in accordance with the manufacturer’s instructions. Taqman assay-identities are presented in Additional file 1: Table S1. Amplification reactions were carried out in triplicate with and started with a 10 min denaturation step at 95 °C followed by 40 cycles of 15 s at 95 °C and 1 minute at 60 °C. All amplification reactions were carried out in 385-well plates using the QuantStudio 12 K Flex (Applied Biosystems/Life Technologies; Stockholm, Sweden) and analysed with QuantStudio software. Technical replicates that evidently differed from the others were excluded from further analysis. The qPCR results were analysed by normalizing the median CT value of the three technical replicates with the average of the median CT values from two reference genes, and the resulting ΔCT values were used for statistical analyses. Rpl19 and Hprt1 were used as housekeeping genes, both of which had stable mRNA expression levels in all samples and between groups (2 h p = 0.91, 8 h p = 0.55 and 2 h p = 0.91, 8 h p = 0.91, respectively) (two-sided student’s t-test).

LacZ staining

To identify cells that express the PGR, we used fallopian tubes from PgrLacZ (+/−) mice. The LacZ mice were adult females who were kept without males, and we did not assess the stage of the cycle at the time of sampling. The fallopian tubes were dissected out and cleaned before they were frozen in OTC medium (Tissue-Tek O.T.C. Sakura Finetek Europe B.V). Then, they were cut into pieces (5–10 μM) in a cryostat (Leica CM3050S, Leica Microsystems AB) and placed on glass slides. To determine the β-galactosidase activity in the tissue we used a LacZ staining kit (InvivoGen, San Diego, USA). The glass slides were prepared according to the manufacturer’s protocol. In cells expressing the LacZ gene, β-galactosidase catalyzes the hydrolysis of X-Gal, producing a blue precipitate that can be visualized under a microscope.

Statistical analyses

The statistical analysis was calculated based on the proportion of mice with at least one OCC present in the fallopian tube, not on the number of OCCs found in the fallopian tube. Fisher´s exact test were used to test if the ratios of mice with OCCs in the fallopian tube differed between mice given vehicle or either of the antagonists. Tests for differential gene expression (qPCR) between control and progesterone-exposed fallopian tubes were performed using two-sided student’s t-test with 0.05 as the alpha-value.


Table 1 presents the percent of mice with OCC present in the fallopian tube after treatment with two PGR antagonists or vehicle at different time points. In mice treated with Org 31710, a significant decrease in the ratio of mice with OCC present in the fallopian tube was found both at 30 h (p = 0.007) and 36 h (p = 0.0256) after hCG treatment. For mice treated with CDB2194, a similar significant decrease in the ratio of mice with OCC present was found at 27 h (p = 0.007) and 30 h (p = 0.0008) after hCG injection. At the doses given, there were no significant differences at any time point between the effects of the two antagonists. These results are consistent with the hypothesis that blockage of the PGR accelerates OCC transport.

Table 1 Progesterone receptor antagonists accelerate the transport of the oocyte cumulus complex (OCC) in mouse fallopian tube

To identify possible progesterone-dependent genes involved in gamete transport and in rapid reduction of CBF, we performed a microarray analysis on fallopian tubes isolated from mice and exposed in vitro to 100 nmol/L progesterone for 20 min and 2 h. Exposure to progesterone for 20 min did not induce any significant change in gene expression in the mouse fallopian tube as assessed by the microarray analysis.

Table 2 provides a list of 11 genes that were differently expressed in mouse fallopian tubes after exposure to progesterone for 2 h compared to control fallopian tubes. Nine of these genes (Arlf4, Rasd1, Edn1, Irak2, Amigo2, Cxcl1, Edn1, P4ha2 and Serpina3n) produce a gene product that is involved in signalling processes. The progesterone induced gene expression changes of three of these genes (Edn1, Amigo2 and Rasd1) were confirmed with qPCR analysis (Fig. 1). The mRNA abundance of Amigo2 was significantly higher after 2 and 8 h of exposure to progesterone (p <0.0001 for both time points, respectively) compared to the controls. The mRNA levels of Rasd1 (p <0.0001 for both time points) and Edn1 (p = 0.043 and p = 0.012) were also significantly increased at both time points. EDN1 is known to be involved in muscular contraction of the human and bovine fallopian tube [1214], and thus, the two other isoforms of endothelin (Edn2 and Edn3) and its receptors (Ednra and Ednrb) were included in the analysis even though they were not identified as regulated by the microarray. We also included Pgr in the analysis because earlier studies have shown a regulation by progesterone in the fallopian tube [21]. Ednra (p = 0.01 and p = 0.004, 2 h and 8 h, respectively) and Pgr (p = 0.004 and p <0.0001) had a lower mRNA abundance after progesterone exposure, whereas there was no significant treatment effect for Edn2 (p = 0.63 and 0.10) and Edn3 (p = 0.25 and 0.29).

Table 2 Genes regulated by progesterone after 2 h in mouse fallopian tubes
Fig. 1
figure 1

Progesterone-regulated gene expression in mouse fallopian tubes. Quantitative PCR analyses of 8 transcripts in mouse fallopian tubes treated with ethanol (EtOH) 0.01 % (v/v) as control (C) or progesterone (P; 100 nmol/L) in vitro for 2 h or 8 h. The relative mRNA abundance in the figure is presented as the normalized value (normalized to the housekeeping genes Hprt and Rpl19). Error bars represent standard error of mean. Significantly different expression between control and exposed fallopian tubes at the two time points is indicated by * (p < 0.05), ** (p < 0.01) or *** (p < 0.001)

To investigate the location of PGR in the mouse fallopian tube, we used fallopian tubes from PGRLacZ mice and a staining kit to detect β-galactosidase activity. As shown in Fig. 2, positive staining was observed in both epithelial and muscle cells.

Fig. 2
figure 2

Localization of the PGR in mouse fallopian tubes. Fallopian tubes from A, cycling, wild-type mice, and B; PGRLacZ mice samples were stained to detect β-galactosidase activity and the location of PGR. Positive blue staining was observed in the epithelial and muscle cells of PGRLacZ (+/−) mice


Previous studies reporting the localization of PGR in the fallopian tube has been based on immunostaining [20, 21]. Here, we applied a method that does not depend on the specificity of antibodies. The results show that a sub-population of both epithelial cells and stromal cells express the PGR. This is consistent with the hypothesis that progesterone regulates both ciliary activity and muscle contractions via the PGR.

We also show that a single dose of two different PGR antagonists causes a rapid disappearance of the OCCs in the mouse fallopian tube. This is consistent with earlier studies showing that in rats and mice treated continuously with antagonists for PGR, the embryos arrived prematurely to the uterus [25, 26].

In a previous study from our laboratory, we showed that the rapid reduction of CBF, which was manifested within 20 min after progesterone administration, was inhibited if the ciliary cells were pre-treated with RU486 and in ciliary cells from mice lacking a functional Pgr [18]. This shows that PGR is most likely involved in this rapid regulation of the CBF. Combining these data with the effect of progesterone antagonists on OCC transport in vivo further indicates an important role of progesterone and the classical nuclear progesterone receptor in this process, which is at least partly mediated by changes in ciliary activity. In this study, we were not able to identify any changes in transcription abundance 20 min after progesterone treatment. Although it cannot be ruled out whether there are genes regulated after 20 min of progesterone exposure that were not discovered with the microarray analyses, our finding is consistent with the hypothesis that PGR regulates ciliary function in the fallopian tube via a non-genomic mechanism. Experiments with blockers of transcription or translation may provide more evidence for this hypothesis.

Transcriptional effects by progesterone were detectable after 2 h, as measured by microarray and qPCR. Nine of the genes that tended to be differentially expressed (Arlf4, Rasd1, Edn1, Irak2, Amigo2, Cxcl1, Edn1, P4ha2 and Serpina3n) produce gene products that are involved in different signalling processes, and some of the genes are regulated by progesterone and Pgr in different cell lines in other studies [3440]. Amigo2 plays a role in cell-adhesion and cell migration. Rasd1 encodes for a protein that is an activator of G-protein signalling. This gene is thought to be involved in nitric oxide signal transduction, which in the fallopian tube has been shown to affect muscle contractility [41, 42].

Most interestingly, Edn1 was differentially expressed, both after 2 and 8 h of progesterone exposure. The absence of apparent regulation at 20 min suggests that progesterone-activation of the endothelin system via gene transcription is not a prerequisite for regulating ciliary function, but its regulation at later time points in the fallopian tube suggests that the endothelin system could be involved in other processes related to gamete transport. Indeed, EDN1 is known to induce muscle contractility in the fallopian tube [11, 12, 43]. Earlier studies show that estrogen and estrogen in combination with progesterone and luteinizing hormone significantly stimulates the production and secretion of EDN1 from bovine oviduct epithelial cells in culture. However, progesterone alone at concentrations ranging from 30 nmol/L to 3 μmol/L caused no significant increase in either production or secretion of EDN1 [44, 45]. In the present study progesterone induced the expression of the Edn1 gene while causing a down-regulation of its receptor, Ednra. The reason for these somewhat contradictory results between the studies might be related to the fact that they are performed in different species using different methodologies. We measured the mRNA abundance in fallopian tubes from immature mice, after in vitro progesterone exposure. The other study measured the cell content and secretion of EDN1 from cultured oviductal epithelial cells from cows sampled during the estrous cycle. Consistent with our results, it has been previously demonstrated that Edn1 is induced by Pgr-A in mouse granulosa cell culture [46].

EDN1 binds to two receptors EDNRA and EDNRB, with equal affinity, but the majority of its effect is mediated through EDNRA [47]. The localization of EDN1 within the human fallopian tube is suggested to be mainly within the tubal epithelium but also to a lesser extent in the muscle layer, while EDNRA is suggested to be dominant in the muscle layer [48]. The Edn1, Edn2 and Edn3 as well as the Ednra and Ednrb genes are reported to be expressed in bovine and mice oviducts during the estrous cycle [14, 49]. Consistently, we detected mRNA from all three endothelin isoforms and both receptors using qPCR. The expression of Edn2, Edn3 and Ednrb was, however, very low compared to Edn1 and Ednra, and only Edn1 and Ednra were differently expressed after exposure to progesterone. In the bovine oviduct, the expression of EDN1, EDNRA and EDNRB mRNA was highest during the peri-ovulatory period. During this period, EDN1 also caused the highest increase in oviduct contraction. In bovine oviduct epithelial cells, EDN1 stimulates the production and release of prostaglandins. This suggests that in the bovine oviduct, EDN1 produced by the oviduct has a major role in the control of local contractions during the transport of gametes/embryos [14]. Our results indicate that the endothelin signalling is likely regulated, in turn, by progesterone.

We are not aware of any previous studies of Ednra regulation in the fallopian tube. Zhang et al. showed that Ednra was up-regulated in different tissues after progesterone treatment as well as in pregnant mice [46]. We found a down regulation of Ednra in the fallopian tube, suggesting that progesterone might regulate Ednra-expression in different directions depending on the tissue. When the controls for Ednra were compared, a decrease in mRNA abundance between the 2 h and 8 h samples was discovered. This decrease in abundance could either be due to less transcription and/or decreased stability of the mRNA.

In both the mouse and human fallopian tube, both isoforms of PGR are highly expressed [20]. In humans, the expression seems to vary across the menstrual cycle and differ between the different parts of the fallopian tube [50]. In our study, Pgr mRNA was down-regulated by progesterone, which is consistent with results from an earlier study showing that there was a time-dependent reduction of PGRA and PGRB protein expression in immature mice treated with a single dose of progesterone [21].

Ednra and Pgr were not markedly affected by the progesterone treatment as measured by the microarray analysis at 20 min or 2 h. However, with qPCR, significantly lowered mRNA levels after progesterone treatment were identified at both 2 h and 8 h in a separate experiment. One reason for this apparent difference at 2 h could be that both are receptors, and therefore, their expression is low compared to many other types of mRNA. A microarray has a considerably higher detection limit than a qPCR assay; thus, changes in genes that are hardly detectable by a microarray are much more subjected to noise than more highly expressed genes. A second reason might be that a gene might only be present and regulated in a small subset of the cells analysed, making it difficult to find small changes because they can drown in the noise from other cells. A third explanation could also be that the arrays were only performed with a replication of four per group, while the smaller amount of RNA required for the qPCR allowed us to analyze 9 biological replicates per treatment group, providing much higher statistical power.

A recent study investigated the differences in gene expression in fallopian tubes of mice completely lacking a functional Pgr (PgrLacZ mice) and heterozygous mice (PgrLacZ (+/−)) carrying one copy of the Pgr gene using both microarray and qPCR [51]. However, the overlap of the differentially expressed genes in that study and the genes found to be regulated directly by progesterone in the present study was small. Indeed, comparing the difference in gene expression between the two genotypes will reveal differences that are also indirectly affected by the lack of the receptor. Indeed, of the 9 genes investigated by qPCR after stimulation of ovulation in immature mice by hCG (thus inducing a progesterone-surge), 6 genes differed before treatment between the two genotypes. The authors identified an up-regulation of Edn3 in heterozygous mice 8 hours after hCG treatment, while we did not observe any changes of Edn3 either at 2 or 8 h after progesterone treatment. This suggests that the up-regulation of Edn3 found during induced ovulation in the fallopian tube in the other study is not a direct effect of PGR activation.


To our best knowledge, this is the first study demonstrating that Edn1 and Ednra are directly regulated by progesterone in the mouse fallopian tube. We also confirm that PGR antagonists accelerate the transport of the OCC through the fallopian tube. Our results further support that progesterone and PGR plays an essential role in OCC transport that involves both non-genomic and genomic mechanisms. It is important to reveal the mechanisms and regulation of gamete transport in the fallopian tube because it is an essential step in natural reproduction and may contribute to a better understanding of the causes of infertility in women and the development of new and better contraceptives. To better understand the role of progesterone in the fallopian tube, studies on gene regulation in vivo would be important to perform in the future.



Ciliary beat frequency


Endothelin 1


Endothelin 2


Endothelin 3


Endothelin receptor A


Endothelin receptor B


Human chorionic gonadotropin


Membrane progesterone receptors


Oocyte cumulus complex


Prostaglandins E-series


Prostaglandins F-series


Progesterone receptor


Pregnant mare's serum gonadotropin


Quantitative PCR




  1. Croxatto HB, Ortiz ME. Egg transport in the fallopian tube. Gynecol Invest. 1975;6(3–4):215–25.

    Article  CAS  PubMed  Google Scholar 

  2. Mahmood T, Saridogan E, Smutna S, Habib AM, Djahanbakhch O. The effect of ovarian steroids on epithelial ciliary beat frequency in the human Fallopian tube. Hum Reprod. 1998;13(11):2991–4.

    Article  CAS  PubMed  Google Scholar 

  3. Lyons RA, Saridogan E, Djahanbakhch O. The effect of ovarian follicular fluid and peritoneal fluid on Fallopian tube ciliary beat frequency. Hum Reprod. 2006;21(1):52–6.

    Article  CAS  PubMed  Google Scholar 

  4. Bylander A, Nutu M, Wellander R, Goksor M, Billig H, Larsson DGJ. Rapid effects of progesterone on ciliary beat frequency in the mouse fallopian tube. Reprod Biol Endocrinol. 2010;8:48.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Graham JD, Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev. 1997;18(4):502–19.

    CAS  PubMed  Google Scholar 

  6. Bishop CV, Stormshak F. Non-genomic actions of progesterone and estrogens in regulating reproductive events in domestic animals. Vet J. 2008;176(3):270–80.

    Article  CAS  PubMed  Google Scholar 

  7. Frye CA. Steroids, reproductive endocrine function, and cognition: A review. Minerva Ginecol. 2009;61(6):563–85.

    CAS  PubMed  Google Scholar 

  8. Akison LK, Robker RL. The critical roles of progesterone receptor (PGR) in ovulation, oocyte developmental competence and oviductal transport in mammalian reproduction. Reprod Domest Anim. 2012;47 Suppl 4:288–96.

    Article  PubMed  Google Scholar 

  9. Wanggren K, Stavreus-Evers A, Olsson C, Andersson E, Gemzell-Danielsson K. Regulation of muscular contractions in the human Fallopian tube through prostaglandins and progestagens. Hum Reprod. 2008;23(10):2359–68.

    Article  CAS  PubMed  Google Scholar 

  10. Helm G, Owman C, Sjoberg NO, Walles B. Motor activity of the human Fallopian tube in vitro in relation to plasma concentration of oestradiol and progesterone, and the influence of noradrenaline. J Reprod Fertil. 1982;64(1):233–42.

    Article  CAS  PubMed  Google Scholar 

  11. Al-Alem L, Bridges PJ, Su W, Gong MC, Iglarz M, Ko C. Endothelin-2 induces oviductal contraction via endothelin receptor subtype A in rats. J Endocrinol. 2007;193(3):383–91.

    Article  CAS  PubMed  Google Scholar 

  12. Jankovic SM, Jankovic SV, Lukic G, Canovic D, Folic M. The contractile effects of endothelins on isolated isthmic segment of human oviduct at the luteal phase of the menstrual cycle. Methods Find Exp Clin Pharmacol. 2010;32(2):91–5.

    CAS  PubMed  Google Scholar 

  13. Jankovic SM, Jankovic SV, Lukic G, Radonjic V, Cupara S, Stefanovic S. Contractile effects of endothelins on isolated ampullar segment of human oviduct in luteal phase of menstrual cycle. Pharmacol Res. 2009;59(1):69–73.

    Article  CAS  PubMed  Google Scholar 

  14. Priyadarsana M, Wijayagunawardane B, Miyamoto A. Endothelin-1 system in the bovine oviduct: a regulator of local contraction and gamete transport. J Cardiovasc Pharmacol. 2004;44 Suppl 1:S248–51.

    Article  PubMed  Google Scholar 

  15. Lindblom B, Hamberger L, Ljung B. Contractile patterns of isolated oviductal smooth muscle under different hormonal conditions. Fertil Steril. 1980;33(3):283–7.

    CAS  PubMed  Google Scholar 

  16. Spilman CH, Harper MJ. Effects of prostaglandins on oviductal motility and egg transport. Gynecol Invest. 1975;6(3–4):186–205.

    Article  CAS  PubMed  Google Scholar 

  17. Wanggren K, Lalitkumar PG, Stavreus-Evers A, Stabi B, Gemzell-Danielsson K. Prostaglandin E2 and F2alpha receptors in the human Fallopian tube before and after mifepristone treatment. Mol Hum Reprod. 2006;12(9):577–85.

    Article  CAS  PubMed  Google Scholar 

  18. Bylander A, Lind K, Goksor M, Billig H, Larsson DGJ. The classical progesterone receptor mediates the rapid reduction of fallopian tube ciliary beat frequency by progesterone. Reprod Biol Endocrinol. 2013;11(1):33.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Wessel T, Schuchter U, Walt H. Ciliary motility in bovine oviducts for sensing rapid non-genomic reactions upon exposure to progesterone. Horm Metab Res. 2004;36(3):136–41.

    Article  CAS  PubMed  Google Scholar 

  20. Teilmann SC, Clement CA, Thorup J, Byskov AG, Christensen ST. Expression and localization of the progesterone receptor in mouse and human reproductive organs. J Endocrinol. 2006;191(3):525–35.

    Article  CAS  PubMed  Google Scholar 

  21. Shao R, Weijdegard B, Ljungstrom K, Friberg A, Zhu C, Wang X, et al. Nuclear progesterone receptor A and B isoforms in mouse fallopian tube and uterus: implications for expression, regulation, and cellular function. Am J Physiol Endocrinol Metab. 2006;291(1):E59–72.

    Article  CAS  PubMed  Google Scholar 

  22. Zhu Y, Hanna RN, Schaaf MJ, Spaink HP, Thomas P. Candidates for membrane progestin receptors-Past approaches and future challenges. Comp Biochem Physiol C Toxicol Pharmacol. 2008;148(4):381–9.

    Article  PubMed  Google Scholar 

  23. Nutu M, Weijdegård B, Thomas P, Bergh C, Thurin-Kjellberg A, Pang Y, et al. Membrane progesterone receptor gamma: tissue distribution and expression in ciliated cells in the fallopian tube. Mol Reprod Dev. 2007;74(7):843–50.

    Article  CAS  PubMed  Google Scholar 

  24. Nutu M, Weijdegård B, Thomas P, Thurin-Kjellberg A, Billig H, Larsson DGJ. Distribution and hormonal regulation of membrane progesterone receptors beta and gamma in ciliated epithelial cells of mouse and human fallopian tubes. Reprod Biol Endocrinol. 2009;7:89.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Fuentealba B, Nieto M, Croxatto HB. Ovum transport in pregnant rats is little affected by RU486 and exogenous progesterone as compared to cycling rats. Biol Reprod. 1987;37(4):768–74.

    Article  CAS  PubMed  Google Scholar 

  26. Vinijsanun A, Martin L. Effects of progesterone antagonists RU486 and ZK98734 on embryo transport, development and implantation in laboratory mice. Reprod Fertil Dev. 1990;2(6):713–27.

    Article  CAS  PubMed  Google Scholar 

  27. Gainer EE, Ulmann A. Pharmacologic properties of CDB(VA)-2914. Steroids. 2003;68(10–13):1005–11.

    Article  CAS  PubMed  Google Scholar 

  28. Hild SA, Reel JR, Hoffman LH, Blye RP. CDB-2914: anti-progestational/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits. Hum Reprod. 2000;15(4):822–9.

    Article  CAS  PubMed  Google Scholar 

  29. Reel JR, Hild-Petito S, Blye RP. Antiovulatory and postcoital antifertility activity of the antiprogestin CDB-2914 when administered as single, multiple, or continuous doses to rats. Contraception. 1998;58(2):129–36.

    Article  CAS  PubMed  Google Scholar 

  30. Kloosterboer HJ, Deckers GH, Schoonen WG. Pharmacology of two new very selective antiprogestagens: Org 31710 and Org 31806. Hum Reprod. 1994;9 Suppl 1:47–52.

    Article  CAS  PubMed  Google Scholar 

  31. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249–64.

    Article  PubMed  Google Scholar 

  32. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98(9):5116–21.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003;34(2):374–8.

    CAS  PubMed  Google Scholar 

  34. Orbo A, Moe BT, Gronaas H, Paulssen RH. Early effects of high concentrations of progesterone and mifepristone A gene expression study of endometrial cancer cells (Ishikawa). J Steroid Biochem Mol Biol. 2009;113(1–2):139–49.

    Article  CAS  PubMed  Google Scholar 

  35. Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, Frumovitz M, et al. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res. 2005;11(17):6116–26.

    Article  CAS  PubMed  Google Scholar 

  36. Sriraman V, Sinha M, Richards JS. Progesterone receptor-induced gene expression in primary mouse granulosa cell cultures. Biol Reprod. 2010;82(2):402–12.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Srivastava MD, Thomas A, Srivastava BI, Check JH. Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. Leukemia Lymphoma. 2007;48(8):1610–7.

    Article  CAS  PubMed  Google Scholar 

  38. Bray JD, Jelinsky S, Ghatge R, Bray JA, Tunkey C, Saraf K, et al. Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells. J Steroid Biochem Mol Biol. 2005;97(4):328–41.

    Article  CAS  PubMed  Google Scholar 

  39. Lee Y, Sooranna SR, Terzidou V, Christian M, Brosens J, Huhtinen K, et al. Interactions between inflammatory signals and the progesterone receptor in regulating gene expression in pregnant human uterine myocytes. J Cell Mol Med. 2012;16(10):2487–503.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Su S, Blackwelder AJ, Grossman G, Minges JT, Yuan L, Young SL, et al. Primate-specific melanoma antigen-A11 regulates isoform-specific human progesterone receptor-B transactivation. J Biol Chem. 2012;287(41):34809–24.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Ekerhovd E, Brannstrom M, Alexandersson M, Norstrom A. Evidence for nitric oxide mediation of contractile activity in isolated strips of the human Fallopian tube. Hum Reprod. 1997;12(2):301–5.

    Article  CAS  PubMed  Google Scholar 

  42. Ekerhovd E, Brannstrom M, Weijdegard B, Norstrom A. Localization of nitric oxide synthase and effects of nitric oxide donors on the human Fallopian tube. Mol Hum Reprod. 1999;5(11):1040–7.

    Article  CAS  PubMed  Google Scholar 

  43. Wijayagunawardane MP, Miyamoto A, Cerbito WA, Acosta TJ, Takagi M, Sato K. Local distributions of oviductal estradiol, progesterone, prostaglandins, oxytocin and endothelin-1 in the cyclic cow. Theriogenology. 1998;49(3):607–18.

    Article  CAS  PubMed  Google Scholar 

  44. Wijayagunawardane MP, Choi YH, Miyamoto A, Kamishita H, Fujimoto S, Takagi M, et al. Effect of ovarian steroids and oxytocin on the production of prostaglandin E2, prostaglandin F2alpha and endothelin-1 from cow oviductal epithelial cell monolayers in vitro. Anim Reprod Sci. 1999;56(1):11–7.

    Article  CAS  PubMed  Google Scholar 

  45. Wijayagunawardane MP, Miyamoto A, Sato K. Prostaglandin E2, prostaglandin F2 alpha and endothelin-1 production by cow oviductal epithelial cell monolayers: effect of progesterone, estradiol 17 beta, oxytocin and luteinizing hormone. Theriogenology. 1999;52(5):791–801.

    Article  CAS  PubMed  Google Scholar 

  46. Zhang Y, Knutsen GR, Brown MD, Ruest LB. Control of endothelin-a receptor expression by progesterone is enhanced by synergy with Gata2. Mol Endocrinol. 2013;27(6):892–908.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  47. Apa R, Miceli F, de Feo D, Mastrandrea ML, Mancuso S, Napolitano M, et al. Endothelin-1 inhibits basal and human chorionic gonadotrophin-stimulated progesterone production. Hum Reprod. 1998;13(9):2425–9.

    Article  CAS  PubMed  Google Scholar 

  48. Sakamoto M, Sakamoto S, Kubota T, Aso T, Azuma H. Localization and role of endothelin-1 and endothelin receptors in the human Fallopian tube. Mol Hum Reprod. 2001;7(11):1057–63.

    Article  CAS  PubMed  Google Scholar 

  49. Jeoung M, Lee S, Hawng HK, Cheon YP, Jeong YK, Gye MC, et al. Identification of a novel role for endothelins within the oviduct. Endocrinology. 2010;151(6):2858–67.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  50. Pollow K, Inthraphuvasak J, Manz B, Grill HJ, Pollow B. A comparison of cytoplasmic and nuclear estradiol and progesterone receptors in human fallopian tube and endometrial tissue. Fertil Steril. 1981;36(5):615–22.

    CAS  PubMed  Google Scholar 

  51. Akison LK, Boden MJ, Kennaway DJ, Russell DL, Robker RL. Progesterone receptor (PGR) dependent regulation of genes in the oviducts of female mice. Physiol Genomics. 2014;46(16):583–92.

    Article  CAS  PubMed  Google Scholar 

Download references


We thank the Swegene Center for Integrative Biology at Lund University for help with the microarray laboratory work and analysis and the Genomics Core Facility platform at the Sahlgrenska Academy, University of Gothenburg for help with the qPCR analysis. We thank American Journal Experts ( for assistance with language and writing style. We also thank Dr Carolin Rutgersson for assistance with tissue sampling. This work was supported by the Swedish Research Council Formas and the Swedish Research Council VR.

Author information

Authors and Affiliations


Corresponding author

Correspondence to DG Joakim Larsson.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

DGJL, HB, AB and LG participated in the design of the study. AB participated in all tissue preparations, in optimizing the total RNA isolation and in the RNA quality control analysis. AB performed the qPCR analysis. AB performed the biological analyses of the gene expression results and drafted the manuscript. LG participated in the tissue preparations, evaluated the microarray results and helped draft the manuscript. The in vivo experiment in mice was planned and performed by RS. DGJL supervised the study, performed some statistical analysis and helped draft the manuscript. All authors read and approved the final manuscript.

Additional file

Additional file 1: Table S1.

Taqman assay-id for primers and probes used for quantitative PCR analysis.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit

The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bylander, A., Gunnarsson, L., Shao, R. et al. Progesterone-mediated effects on gene expression and oocyte-cumulus complex transport in the mouse fallopian tube. Reprod Biol Endocrinol 13, 40 (2015).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: